Statistics
Publications
10
Citations
642
H-Index
10
Active since
2001
Mingen Lin is an author at Fudan University specializing in medicine, oncology, and molecular oncology.
Publications per year
2001–2024
10
10
Novel mutations of CYP3A4 in Chinese.
K-C. Hsieh, Chuanmin Cheng, Ming‐Liang Lai et al. · PubMed · 2001 · 187 citations
Medicine, Genetics, Pharmacology +16
TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling
Xinchao Zhang, Shuyan Li, Jing He et al. · Cancer Research · 2022 · 68 citations
Targeting fibrinogen-like protein 1 enhances immunotherapy in hepatocellular carcinoma
Mingen Lin, Jing He, Xinchao Zhang et al. · Journal of Clinical Investigation · 2023 · 60 citations · Full text
Medicine, Oncology, Pharmacology +17
TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential
Jing He, Mingen Lin, Xinchao Zhang et al. · Cell Discovery · 2023 · 25 citations · Full text
1–5 of 10